Search research articles
Contact Us
Filters
Showing results (261-270 of 410) with videos related to
Page
of 41
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
September 14, 2023
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN study
Axel S Merseburger, Neeraj Agarwal, Amitabha Bhaumik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2020
Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers
Suzanne J Forrest, Alyaa Al-Ibraheemi, Duong Doan, et al.
Journal of Neuro-Oncology
|
April 14, 2017
Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach
Taryn B Fay-McClymont, Danielle M Ploetz, Don Mabbott, et al.
Cancer Discovery
|
January 26, 2018
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Matti Annala, Gillian Vandekerkhove, Daniel Khalaf, et al.
The Lancet. Oncology
|
December 19, 2015
Classification of treatment-related mortality in children with cancer: a systematic assessment
Sarah Alexander, Jason D Pole, Paul Gibson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2017
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Birgit Geoerger, Franck Bourdeaut, Steven G DuBois, et al.
European Urology Oncology
|
December 10, 2023
Post Hoc Analysis of Rapid and Deep Prostate-specific Antigen Decline and Patient-reported Health-related Quality of Life in SPARTAN and TITAN Patients with Advanced Prostate Cancer
Eric J Small, Kim N Chi, Simon Chowdhury, et al.
Cancer Chemotherapy and Pharmacology
|
March 23, 2021
Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE)
Fred Saad, Kim N Chi, Neal D Shore, et al.
The Journal of Urology
|
July 26, 2024
Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of the TITAN Trial
Soumyajit Roy, Yilun Sun, Kim N Chi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
August 28, 2020
Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialists
Sebastien J Hotte, Antonio Finelli, Kim N Chi, et al.
Page
of 41
Search research articles
Search
Showing results (261-270 of 410) with videos related to
Sort By:
Page
of 41
European Journal of Cancer (Oxford, England : 1990)
|
September 14, 2023
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN study
Axel S Merseburger, Neeraj Agarwal, Amitabha Bhaumik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2020
Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers
Suzanne J Forrest, Alyaa Al-Ibraheemi, Duong Doan, et al.
Journal of Neuro-Oncology
|
April 14, 2017
Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach
Taryn B Fay-McClymont, Danielle M Ploetz, Don Mabbott, et al.
Cancer Discovery
|
January 26, 2018
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Matti Annala, Gillian Vandekerkhove, Daniel Khalaf, et al.
The Lancet. Oncology
|
December 19, 2015
Classification of treatment-related mortality in children with cancer: a systematic assessment
Sarah Alexander, Jason D Pole, Paul Gibson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2017
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Birgit Geoerger, Franck Bourdeaut, Steven G DuBois, et al.
European Urology Oncology
|
December 10, 2023
Post Hoc Analysis of Rapid and Deep Prostate-specific Antigen Decline and Patient-reported Health-related Quality of Life in SPARTAN and TITAN Patients with Advanced Prostate Cancer
Eric J Small, Kim N Chi, Simon Chowdhury, et al.
Cancer Chemotherapy and Pharmacology
|
March 23, 2021
Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE)
Fred Saad, Kim N Chi, Neal D Shore, et al.
The Journal of Urology
|
July 26, 2024
Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of the TITAN Trial
Soumyajit Roy, Yilun Sun, Kim N Chi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
August 28, 2020
Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialists
Sebastien J Hotte, Antonio Finelli, Kim N Chi, et al.
Page
of 41